Pertuzumab: neuer Standard für die Erstlinien-Behandlung von Patientinnen mit HER2-positivem, metastasiertem Mammakarzinom
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Dokumenttyp: | Book/Monograph |
| Sprache: | Deutsch |
| Veröffentlicht: |
Stuttgart [u.a.]
Thieme
2015
|
| Schriftenreihe: | Thieme drug report
2015,10 |
| In: |
Thieme drug report (2015,10)
|
| Online-Zugang: | Inhaltsverzeichnis: http://d-nb.info/1071362747/04 |
| Verfasserangaben: | [Hrsg. Andreas Schneeweiss ...] |
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1503506932 | ||
| 003 | DE-627 | ||
| 005 | 20240505000405.0 | ||
| 007 | tu | ||
| 008 | 150608s2015 xx ||||| 00| ||ger c | ||
| 035 | |a (DE-627)1503506932 | ||
| 035 | |a (DE-576)433506938 | ||
| 035 | |a (DE-599)BSZ433506938 | ||
| 035 | |a (OCoLC)912985550 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Pertuzumab |b neuer Standard für die Erstlinien-Behandlung von Patientinnen mit HER2-positivem, metastasiertem Mammakarzinom |c [Hrsg. Andreas Schneeweiss ...] |
| 264 | 1 | |a Stuttgart [u.a.] |b Thieme |c 2015 | |
| 300 | |a 14 S. |b Ill. | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 490 | 1 | |a Thieme drug report |v 2015,10 | |
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |f PEBW |h DE-24 |x XA-DE-BW |2 pdager |5 DE-31 | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e Hrsg. |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 edt | |
| 830 | 0 | |a Thieme drug report |v 2015,10 |9 2015,10 |w (DE-627)547222505 |w (DE-576)275732320 |w (DE-600)2393126-7 |x 1865-2875 |7 am | |
| 856 | 4 | 2 | |u http://d-nb.info/1071362747/04 |m B:DE-101 |q application/pdf |3 Inhaltsverzeichnis |
| 951 | |a BO | ||
| 992 | |a 20200302 | ||
| 993 | |a Book | ||
| 994 | |a 2010 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1503506932 |e 3601351064 | ||
| BIB | |a Y | ||
| JSO | |a {"type":{"bibl":"edited-book"},"name":{"displayForm":["[Hrsg. Andreas Schneeweiss ...]"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015","publisherPlace":"Stuttgart [u.a.]","publisher":"Thieme"}],"recId":"1503506932","person":[{"role":"edt","family":"Schneeweiss","given":"Andreas","display":"Schneeweiss, Andreas"}],"title":[{"title":"Pertuzumab","subtitle":"neuer Standard für die Erstlinien-Behandlung von Patientinnen mit HER2-positivem, metastasiertem Mammakarzinom","title_sort":"Pertuzumab"}],"id":{"eki":["1503506932"]},"relMultPart":[{"language":["ger","eng"],"physDesc":[{"noteFormat":"28 cm"}],"disp":"Thieme drug report","part":{"number_sort":["2015,10"],"number":["2015,10"]},"dispAlt":"Thieme drug report","titleAlt":[{"title":"Drug report"},{"title":"Thieme drug-report"}],"recId":"547222505","id":{"eki":["547222505"],"zdb":["2393126-7"],"issn":["1865-2875"]},"origin":[{"dateIssuedDisp":"2007-2017","publisher":"Thieme","publisherPlace":"Stuttgart ; New York, NY","dateIssuedKey":"2007"}],"type":{"bibl":"serial"},"title":[{"title":"Thieme drug report","title_sort":"Thieme drug report"}],"pubHistory":["1.2007,1-3; 2.2008 - 3.2009 = Nr. 1-14; 3.2009,2 - 11.2017,1"]}],"language":["ger"],"physDesc":[{"extent":"14 S.","noteIll":"Ill."}]} | ||
| SRT | |a PERTUZUMAB2015 | ||